80.82 USD
+1.68 (+2.12%)
80.9936 USD
+0.17 (+0.21%)
ChartMill assigns a Buy % Consensus number of 83% to IONS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 85.6. This target is 5.92% above the current price.
IONS was analyzed by 30 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IONS.
In the previous month the buy percentage consensus was at a similar level.
IONS was analyzed by 30 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-09 | B of A Securities | Maintains | Buy -> Buy |
| 2025-11-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-04 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-30 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-30 | Needham | Maintains | Buy -> Buy |
| 2025-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-30 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-30 | Raymond James | Reiterate | Strong Buy -> Strong Buy |
| 2025-10-30 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-30 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-08 | Needham | Maintains | Buy -> Buy |
| 2025-10-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-10-08 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2025-10-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-10-06 | Stifel | Maintains | Hold -> Hold |
| 2025-09-26 | Goldman Sachs | Upgrade | Sell -> Neutral |
| 2025-09-23 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-23 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-23 | B of A Securities | Maintains | Buy -> Buy |
| 2025-09-23 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-09-03 | BMO Capital | Upgrade | Market Perform -> Outperform |
| 2025-09-03 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-03 | Goldman Sachs | Maintains | Sell -> Sell |
| 2025-09-03 | Citigroup | Maintains | Buy -> Buy |
| 2025-09-02 | Needham | Maintains | Buy -> Buy |
| 2025-09-02 | Jefferies | Maintains | Buy -> Buy |
| 2025-09-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
IONIS PHARMACEUTICALS INC / IONS FAQ
What is the price target for IONS stock?
30 analysts have analysed IONS and the average price target is 85.6 USD. This implies a price increase of 5.92% is expected in the next year compared to the current price of 80.82.
Can you provide the consensus rating for IONIS PHARMACEUTICALS INC stock?
The consensus rating for IONIS PHARMACEUTICALS INC (IONS) is 82.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.